Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     Neurology Devices Market     Nerve Repair & Regeneration Market    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Neurostimulation/Neuromodulation Market

  • Report Code: HE 1025
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The global Neurostimulation/Neuromodulation market is driven by aging population and associated diseases like Alzheimer’s, epilepsy, spinal cord injury, and Parkinson’s disease. The market value is expected to reach from $4,503.9 to $7,810.4 million from 2013 to 2018, at a CAGR of 11.60%. The market value is expected to grow due to technical advances and patient-friendly techniques which are minimally invasive and non-invasive. The neurostimulation/neuromodulation market is the largest market with a share of 96% of the total nerve repair and regeneration market.

 

The report “Neurostimulation/Neuromodulation Market Forecast, 20012-2018”, analyzes the market into two types of neuromodulation such as internal and external. The market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external stimulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS).

 

The segmentation experienced a positive growth till 2013 with an increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $3.9 and $0.6 billion, internal and external neuromodulation accounted around 87% and 13% share in terms of value towards total neuromodulation device. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of SCS, DBS, VNS, SNS, GES, TMS, and TENS.

 

Procedure volume growth is higher in BIC (Brazil, India, and China) and Mexico because of fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people.

 

According to the International Neurostimulation Society, about 40-50 million patients worldwide suffer from epilepsy and 1.5 million from Parkinson’s in the U.S. alone. A wide pool of patients suffering from other conditions such as depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor are also an influential factor in triggering the market towards growth. Treatment for tinnitus represents one of the emerging applications in this market. According to the American Tinnitus Association, about 50 million people suffer from the disease in the U.S. alone.

 

The prevalence of Alzeimer’s in Europe and North America is around 6.4-5.4% in adult population whereas in Asia, it is around 4%. The prevalence in Asia is because of maximum aging population whereas in North America and Europe it’s because of obese population and diabetes. The incidence of Alzheimer’s was estimated to be 411,000 in 2000. This was expected to increase to 454,000 in 2010, 615,000 by 2030 and 959,000 by 2050. Such high incidence rates in neurological disorders will positively affect the market for neuromodulation.

 

The report provides an extensive competitive landscaping of companies operating in this market. Major players of the market covered in the report are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), EnteroMedics, Inc. (U.S.), Dynatronics Corporation (U.S.), and Neuronetics (U.S.). Some emerging players of the market are Functional Neuromodulation,Ltd (U.S.), MicroTransponder,Inc. (U.S.), Zynex Medical, Inc. (U.S.), and Neurotech SA (Belgium). The details of segment and country-specific company shares, news and deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies is covered in the report.

 

Customization Options

 

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment-wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • End-user adoption rate analysis of the products (segment and country wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

 

Epidemiology Data

  • Country-specific prevalence, incidence, and patient pool of Alzheimer’s ,Parkinson’s, epilepsy,and stroke
  • Country-specific mortality rate of stroke and epilepsy
  • Disease progression (pattern analysis)

 

Procedure Volume Data

  • Number of surgeries for epilepsy, heart failure, Alzheimer’s and Parkinson’s country wise

 

Surgeons/Physicians Perception Analysis

  • Fast turn-around analysis of surgeons response to market events and trends
  • Pattern analysis of usage of spinal cord stimulation (SCS), deep brain stimulation (DBS) by physicians
  • Surgeon’s opinion about products from different companies
  • Surgeon’s qualitative inputs on epidemiology data

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

 

Pricing Trends

  • Cost analysis of Neurostimulation/Neuromodulation devices in major countries
  • Internal Neurostimulation/Neuromodulation procedural investment in major countries

 

Competitive Intelligence

  • The company share analysis for the top players of the Neurostimulation/Neuromodulation market in the region
  • The crucial developments and strategies of companies inculcating in their portfolio for Neurostimulation/Neuromodulation


Table Of Contents

1 Introduction (Page No. - 9)
    1.1 Objectives Of The Study 
    1.2 Market Segmentation & Coverage 
    1.3 Stakeholders 
2 Research Methodology (Page No. - 11)
    2.1 Integrated Ecosystem Of Internal Neurostimulation/ Neuromodulation Market 
    2.2 Arriving At The Neuromostimulation/Neuromodulation Market Size 
           2.2.1 Market Share
           2.2.2 Top-Down Approach
3 Executive Summary (Page No. - 13)
4 Market Overview (Page No. - 15)

    4.1 Introduction 
    4.2 Internal Neurostimulation/Neuromodulation Market: Comparison With Parent Market 
    4.3 Market Drivers And Inhibitors 
5 Internal Neurostimulation/Neuromodulation Market, By Modality (Page No. - 20)
    5.1 Introduction 
    5.2 Spinal Cord Stimulation 
    5.3 Deep Brain Stimulation 
    5.4 Sacral Nerve Stimulation 
    5.5 Vagus Nerve Stimulaton 
    5.6 Gastric Electrical Stimulation (GES) 
6 Internal Neurostimulation/Neuromodulation Market, By Application (Page No. - 33)
    6.1 Introduction 
           6.1.1 Spinal Cord Stimulation (SCS) Market, By Application/ Geography
                    6.1.1.1 Spinal Cord Stimulation (SCS) Market, By Application
                    6.1.1.2 Spinal Cord Stimulation (SCS) Market, By Geography
           6.1.2 Deep Brain Stimulation (DBS) Market, By Application/ Geography
                    6.1.2.1 Deep Brain Stimulation (DBS) Market, By Application
                    6.1.2.2 Deep Brain Stimulation (DBS) Market, By Geography
           6.1.3 Sacral Nerve Stimulation (SNS) Market, By Application/ Geography
                    6.1.3.1 Sacral Nerve Stimulation (SNS) Market, By Application
                    6.1.3.2 Sacral Nerve Stimulation (SNS) Market, By Geography
           6.1.4 Vagus Nerve Stimulation (Vns) Market, By Application/Geography
                    6.1.4.1 Vagus Nerve Stimulation (Vns) Market, By Application
                    6.1.4.2 Vagus Nerve Stimulation (Vns) Market, By Geography
           6.1.5 Gastric Electrical Stimulation (GES) Market, By Application/ Geography
                    6.1.5.1 Gastric Electrical Stimulation (GES) Market, By Application
                    6.1.5.2 Gastric Electrical Stimulation (GES) Market, By Geography
7 Internal Neurostimulation/Neuromodulation Market: Competitive Landscape (Page No. - 63)
    7.1 Company Share Analysis: By Modality 
           7.1.1 Spinal Cord Stimulation
           7.1.2 Deep Brain Stimulation
           7.1.3 Sacral Nerve Stimulation
           7.1.4 Vagus Nerve Stimulation
    7.2 Company Presence In Internal Neurostimulation/ Neuromodulation Market 
8 Internal Neurostimulation/Neuromodulation Market, By Company (Page No. - 69)
(Overview, Financials, Products & Services, Strategy, And Developments)*
    8.1 Boston Scientific Corporation (U.S.) 
    8.2 Cerbomed Gmbh (Germany) 
    8.3 Cyberonics, Inc. (U.S.) 
    8.4 Enteromedics, Inc. (U.S.) 
    8.5 Medtronic, Inc. (U.S.) 
    8.6 St. Jude Medical (U.S.) 
    8.7 Synapse Biomedical, Inc. (U.S.) 
    8.8 Uroplasty, Inc. (U.S.) 
*Details On Overview, Financials, Product & Services, Strategy, And Developments Might Not Be Captured In Case Of Unlisted Company
9 Appendix (Page No. - 82)
    9.1 Customization Options 
           9.1.1 Product Analysis
           9.1.2 Epidemiology Data
           9.1.3 Surgeons/Physicians Perception Analysis
           9.1.4 Regulatory Framework
    9.2 Related Reports 
    9.3 Introducing Rt: Real-Time Market Intelligence 
           9.3.1 Snapshots


List Of Tables 
 
Table 1 Global Internal Neurostimulation/Neuromodulation Market: Comparison With Parent Market, 2012 – 2019 (USD Million)
Table 2 Internal Neuromodulation/Neurostimulation Market, By Geography, 2012 – 2019 (USD Thousand)
Table 3 Internal Neuromodulation/Neurostimulation Market In Saudi Arabia, South Africa, And Turkey: Drivers And Inhibitors
Table 4 Internal Neurostimulation/Neuromodulation Market In South Africa, By Modality, 2013 - 2019 (USD Thousand) 
Table 5 Internal Neurostimulation/Neuromodulation Market In Turkey, By Modality, 2012 – 2019 (USD Thousand) 
Table 6 Internal Neurostimulation/Neuromodulation Market In Saudi Arabia, By Modality, 2012 – 2019 (USD Thousand) 
Table 7 Spinal Cord Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Table 8 Deep Brain Stimulation Market, By Geography, 2012–2019 (USD Thousand)
Table 9 Sacral Nerve Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Table 10 Vagus Nerve Stimulation Market, By Geography, 2012–2019 (USD Mn)
Table 11 Gastric Electrical Stimulation Masks Market, By Geography, 2013–2019 (USD Thousand) 
Table 12 Spinal Cord Stimulation (SCS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Table 13 Spinal Cord Stimulation (SCS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 14 Spinal Cord Stimulation (SCS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Table 15 Chronic Pain Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Table 16 Failed Back Surgery Syndrome Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 17 Ischemia Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 18 Deep Brain Stimulation (DBS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Table 19 Deep Brain Stimulation (DBS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 20 Deep Brain Stimulation (DBS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Table 21 Parkinson’s Disease Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Table 22 Tremor Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 23 Depression Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2013 - 2019 (USD Thousand)
Table 24 Sacral Nerve Stimulation (SNS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand)
Table 25 Sacral Nerve Stimulation (SNS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 26 Sacral Nerve Stimulation (SNS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand)
Table 27 Urinary Incontinence Segment In Sacral Nerve Stimulation (SNS) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 28 Fecal Incontinence Segment In Sacral Nerve Stimulation (SNS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Table 29 Vagus Nerve Stimulation (Vns) Market In South Africa, By Application, 2012 – 2019 (USD Thousand)
Table 30 Vagus Nerve Stimulation (Vns) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 31 Vagus Nerve Stimulation (Vns) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Table 32 Epilepsy Segment In Vagus Nerve Stimulation (Vns) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 33 Gastric Electrical Stimulation (GES) Market In South Africa, By Application, 2012- 2019 (USD Thousand) 
Table 34 Gastric Electrical Stimulation (GES) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 35 Gastric Electrical Stimulation (GES) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Table 36 Gastroparesis Segment In Gastric Electrical Stimulation (GES) Market, By Geography, 2012 – 2019 (USD Thousand) 
Table 37 Boston Scientific Corporation: Key Financials, By Segments, 2009 – 2013 (USD Million) 
Table 38 Boston Scientific: Key Financials, By Geography, 2009 – 2012 (USD Million)
Table 39 Cyberonics, Inc.: Key Financials, 2009 - 2013 (USD Million)
Table 40 Medtronic, Inc. : Key Financials, By Segments, 2009 - 2013 (USD Million)
Table 41 Medtronic, Inc. : Key Financials, 2009 - 2013 (USD Million)
Table 42 St. Jude Medical: Key Financials, By Segments, 2011 - 2013 (USD Million)
Table 43 St. Jude Medical: Key Financials, By Geography, 2008 - 2013 (USD Million)
Table 44 Uroplasty, Inc. : Key Financials, By Geography, 2011 - 2013 (USD Million)
 
 
List Of Figures 
 
Figure 1 Neurostimulation/Neuromodulation Market In Saudi Arabia, South Africa, And Turkey: Segmentation & Coverage 
Figure 2 Internal Neurostimulation/Neuromodulation Market: Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Global Internal Neurostimulation/Neuromodulation Market: Comparison With Parent Market, 2012 – 2018 (USD Million)
Figure 5 Internal Neuromodulation/Neurostimulation Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 6 Internal Neurostimulation/Neuromodulation Market In South Africa, By Modality, 2013–2019 (USD Thousand) 
Figure 7 Internal Neurostimulation/Neuromodulation Market In Turkey, By Modality, 2013–2019 (USD Thousand) 
Figure 8 Internal Neurostimulation/Neuromodulation Market In Turkey, By Modality, 2013–2019 (USD Thousand) 
Figure 9 Spinal Cord Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Figure 10 Deep Brain Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Figure 11 Sacral Nerve Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Figure 12 Vagus Nerve Stimulation Market, By Geography, 2013–2019 (USD Mn)
Figure 13 Gastric Electrical Stimulation Masks Market, By Geography, 2013–2019 (USD Thousand) 
Figure 14 Spinal Cord Stimulation (SCS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Figure 15 Spinal Cord Stimulation (SCS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 16 Spinal Cord Stimulation (SCS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Figure 17 Chronic Pain Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Figure 18 Failed Back Surgery Syndrome Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 19 Ischemia Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 20 Deep Brain Stimulation (DBS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Figure 21 Deep Brain Stimulation (DBS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 22 Deep Brain Stimulation (DBS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Figure 23 Parkinson’s Disease Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Figure 24 Tremor Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 25 Depression Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 26 Sacral Nerve Stimulation (SNS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand)
Figure 27 Sacral Nerve Stimulation (SNS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 28 Sacral Nerve Stimulation (SNS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand)
Figure 29 Urinary Incontinence Segment In Sacral Nerve Stimulation (SNS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 30 Fecal Incontinence Segment In Sacral Nerve Stimulation (SNS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Figure 31 Vagus Nerve Stimulation (Vns) Market In South Africa, By Application, 2012 – 2019 (USD Thousand)
Figure 32 Vagus Nerve Stimulation (Vns) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 33 Vagus Nerve Stimulation (Vns) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Figure 34 Epilepsy Segment In Vagus Nerve Stimulation (Vns) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 35 Gastric Electrical Stimulation (GES) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Figure 36 Gastric Electrical Stimulation (GES) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 37 Gastric Electrical Stimulation (GES) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand)
Figure 38 Gastroparesis Segment In Gastric Electrical Stimulation (GES) Market, By Geography, 2012 – 2019 (USD Thousand) 
Figure 39 South Africa : Spinal Cord Stimulation , By Company, 2014
Figure 40 Saudi Arabia : Spinal Cord Stimulation , By Company, 2014
Figure 41 Turkey : Spinal Cord Stimulation , By Company, 2014
Figure 42 South Africa : Deep Brain Stimulation , By Company, 2014
Figure 43 Saudi Arabia : Deep Brain Stimulation , By Company, 2014
Figure 44 Turkey : Deep Brain Stimulation , By Company, 2014
Figure 45 South Africa : Vagus Nerve Stimulation , By Company, 2014
Figure 46 Saudi Arabia : Vagus Nerve Stimulation , By Company, 2014
Figure 47 Turkey : Vagus Nerve Stimulation , By Company, 2014
Figure 48 Internal Neurostimulation/ Neuromodulation Market: Company Coverage, By Product, 2013

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Neurostimulation/Neuromodulation Market

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Asian Internal Neurostimulation Asian Internal Neurostimulation
The Asian internal neurostimulation market was $271.80 million in 2013, and expected to reach $546.6 million by 2018 at a CAGR of 15.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Johnson & Johnson and Greenbatch Inc,.
Mar 2015
Global Internal Neurostimulation Market Global Internal Neurostimulation Market
The Internal Neurostimulation market was $3903.2 million in 2013 and expected to reach $6828.8 million by 2018 at a CAGR of 11.8%. The Internal Neuromodulation market is the largest segment 87% of Overall Neurostimulation/Neuromodulation market. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical.
Apr 2015
European Internal Neurostimulation European Internal Neurostimulation
The European internal neurostimulation market was $947.8 million in 2013, and is expected to reach $1715.8 million by 2018 at a CAGR of 13.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S), and Neuronetics, Inc (U.S.). Emerging players in this market include Biocontrol Medical, ANM Neuromodulation GmbH and Magstim Company Limited.
Upcoming
North American Internal Neurostimulation North American Internal Neurostimulation
The North American Internal Neurostimulation market was $2548.27 million in 2013 and expected to reach $4242.09 million by 2018 at a CAGR of 10.7%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical.
Upcoming
Asian Neurostimulation/Neuromodulation devices Market Asian Neurostimulation/Neuromodulation devices Market
The Asian Neurostimulation/Neuromodulation market was expected to reach from $415.32 million in 2013 to $777.62 million by 2018 at a CAGR of 13.4%. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).
Upcoming
European Neurostimulation/Neuromodulation Devices Market European Neurostimulation/Neuromodulation Devices Market
The report also provides a detailed competitive landscaping of companies operating in this market. Segment- and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of major companies are detailed in the report. Boston Scientific (U.S.), Cyberonics (U.S), Medtronic, Inc. (U.S.), Depuy Synthes (Johnson & Johnson) (U.S.), and St. Jude Medical Inc. (U.S.) are some of the key players engaged in this market.
May 2015
North America Internal Neuromodulation Devices Market North America Internal Neuromodulation Devices Market
The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a share of 85.9% in the neuromodulation market.
May 2015
External Neurostimulation External Neurostimulation
The External Neurostimulation market was $600 million in 2013 and expected to reach $983.7 million by 2018 at a CAGR of 10.4%. The External Neurostimulation market segmented by 2 modalities Transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS). Major players in the External Neurostimulation market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). Emerging players include Functional Neuromodulation Ltd. (U.S.), MicroTransponder, Inc. (U.S.), Zynex Medical, Inc. (U.S.) and Neurotech SA – a Sorin Group Company (Belgium).
Upcoming
Spinal cord stimulator Spinal cord stimulator
Spinal cord stimulator and Deep Brain Stimulator, Sacral...
Upcoming
Deep Brain Stimulator Deep Brain Stimulator
Deep Brain Stimulator and Spinal cord stimulator,
Upcoming
Sacral Nerve Stimulator Sacral Nerve Stimulator
Sacral Nerve Stimulator and Spinal cord stimulator, Deep...
Upcoming
Vagus Nerve Stimulator Vagus Nerve Stimulator
Vagus Nerve Stimulator and Spinal cord stimulator, Deep...
Upcoming
Gastric Electrical stimulator Gastric Electrical stimulator
Gastric Electrical stimulator and Spinal cord stimulator,
Upcoming
Transcutaneous Electrical Nerve Stimulation Transcutaneous Electrical Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation adds up to total
Upcoming
Transcranial Magnetic Stimulation Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation and Transcutaneous Electrical Nerve Stimulation adds up to total
Upcoming
North American External Neurostimulation / Neuromodulation devices Market North American External Neurostimulation / Neuromodulation devices Market
The North American external neurostimulation/neuromodulation market is expected to grow significantly due to the growing awareness of consumers and the demand of the aging population to treat prevalent lifestyle & chronic disorders such as arthritis, migraines, and so on. The market report provides information and analysis of the market values, drivers & restraints, competitive scenario, and market opportunities, among others. The U.S., Canada, and Mexico are the major countries that have been considered for this extensive market analysis.
Upcoming
European External Neurostimulation / Neuromodulation devices Market European External Neurostimulation / Neuromodulation devices Market
The European external neurostimulation/neuromodulation market is expected to grow due to the growing demands of the aging population in the region to treat disorders such as arthritis, migraines, and so on. The market report provides market insights such as market values, drivers & restraints, competitive landscape, and market opportunities, among others. The U.K., Germany, France, and Italy, among others, are the major countries that have been considered for this extensive market analysis. 
Upcoming
Asian External Neurostimulation / Neuromodulation  Market Asian External Neurostimulation / Neuromodulation Market
The Asian external neurostimulation/neuromodulation market is expected to grow due to the growing demands of the population in the region to treat lifestyle & chronic disorders such as arthritis, migraines, and so on. Asia is among the fastest-growing markets for these devices. The market report provides insights into market variables such as market values, drivers & restraints, competitive landscape, and market opportunities. Japan, China, and India, among others, are the major countries that have been considered for this extensive market analysis.
Upcoming
Middle East & Africa Internal Neurostimulation/Neuromodulation Market Middle East & Africa Internal Neurostimulation/Neuromodulation Market
The emerging markets such as Saudi Arabia, South Africa, and Turkey have become attractive for companies engaged in the development and marketing of the internal neuromodulation implants.
Feb 2015
Asia-Pacific Internal Neurostimulation/ Neuromodulation Devices Asia-Pacific Internal Neurostimulation/ Neuromodulation Devices
Peers of Internal Neurostimulation/ Neuromodulation Devices - Asia-Pacific are Sacral Nerve Stimulator, Spinal Cord Stimulator, Deep Brain Stimulator and Vagus Nerve Stimulator comprising 5.1%, 0.0%, 0.0% and 0.0% respectively of the Global Internal Neurostimulation/...
Upcoming
20 of 20 items
20 reports | Show
Connect With Us
US/CAN : +1-888-502-0539